N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells

被引:83
作者
Kumar, Santosh [1 ]
Sitasawad, Sandhya L. [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
关键词
Diabetes; Oxidative stress; Glucose oxidase; Mitochondrial damage; Apoptosis; H9c2; cells; CASPASE-3; ACTIVATION; DIABETES-MELLITUS; GENE-EXPRESSION; HEART; RAT; HYPERGLYCEMIA; ANTIOXIDANT; CADMIUM; RELEASE; METALLOTHIONEIN;
D O I
10.1016/j.lfs.2008.12.016
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: High blood glucose may auto-oxidize and generate free radicals, which are proposed to induce apoptosis in cardiac cells. The aim of the present study was to investigate the cell damage induced by glucose/glucose oxidase-dependent oxidative stress and the protective effect of N-acetylcysteine (NAC) on H9c2 cardiac muscle cells. Main methods: H9c2 cells were exposed to 33 mM glucose (G)+1.6 milliunits (mU) of glucose oxidase (GO) and termed G/GO. Cell apoptosis, generation of reactive oxygen species (ROS-super oxide anion and hydrogen peroxide) and reactive nitrogen species (RNS-peroxinitrite), and the change in mitochondrial membrane potential (Delta psi m) was studied using flow cytometry and confocal microscopy, and cytochrome c release was measured using confocal microscopy. The expression of Bcl-2, Bax and the activation of procaspase-9 was studied by western blot. Key findings: Exposure of H9c2 cells to G/GO resulted in a significant increase in cellular apoptosis (P<0.05) and the generation of ROS and RNS (P<0.001). Further, G/GO treatment led to a decrease in Delta psi m, release of cytochrome c, decrease in Bcl-2, increase in Bax expression and the activation of procaspase-9. Treatment with NAC significantly decreased apoptosis (P<0.05) and reduced the levels of ROS and RNS (P<0.001). NAC was also able to normalize Delta psi m, inhibit cytochrome c release, increase Bcl-2 and decrease Bax expression and procaspase-9 activation. Significance: Our studies suggest that NAC has antioxidative and antiapoptotic activity against G/GO-induced oxidative stress through the inhibition of mitochondrial damage in H9c2 cells. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:328 / 336
页数:9
相关论文
共 41 条
[1]   High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases [J].
Allen, DA ;
Harwood, SM ;
Varagunam, M ;
Raftery, MJ ;
Yaqoob, MM .
FASEB JOURNAL, 2003, 17 (03) :908-+
[2]   Biochemical pathways of caspase activation during apoptosis [J].
Budihardjo, I ;
Oliver, H ;
Lutter, M ;
Luo, X ;
Wang, XD .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :269-290
[3]   Oxidative stress and diabetic cardiomyopathy: A brief review [J].
Cai L. ;
Kang Y.J. .
Cardiovascular Toxicology, 2001, 1 (3) :181-193
[4]   Hyperglycemia-induced apoptosis in mouse myocardium -: Mitochondrial cytochrome c-mediated caspase-3 activation pathway [J].
Cai, L ;
Li, W ;
Wang, GW ;
Guo, LP ;
Jiang, YC ;
Kang, YJ .
DIABETES, 2002, 51 (06) :1938-1948
[5]   Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy [J].
Cai, Lu .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 (06) :851-861
[6]   Signalling apoptosis: a radical approach [J].
Carmody, RJ ;
Cotter, TG .
REDOX REPORT, 2001, 6 (02) :77-90
[7]   Triggering and modulation of apoptosis by oxidative stress [J].
Chandra, J ;
Samali, A ;
Orrenius, S .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) :323-333
[8]   WEAK ANTIOXIDANT DEFENSES MAKE THE HEART A TARGET FOR DAMAGE IN COPPER-DEFICIENT RATS [J].
CHEN, Y ;
SAARI, JT ;
KANG, YJ .
FREE RADICAL BIOLOGY AND MEDICINE, 1994, 17 (06) :529-536
[9]   Mitochondria as the central control point of apoptosis [J].
Desagher, S ;
Martinou, JC .
TRENDS IN CELL BIOLOGY, 2000, 10 (09) :369-377
[10]   DIABETES AND EMBRYONIC MALFORMATIONS - ROLE OF SUBSTRATE-INDUCED FREE-OXYGEN RADICAL PRODUCTION FOR DYSMORPHOGENESIS IN CULTURED RAT EMBRYOS [J].
ERIKSSON, UJ ;
BORG, LAH .
DIABETES, 1993, 42 (03) :411-419